Discover 1,776 paid clinical trials in High Point, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,776
Engage Psychosocial Intervention for Cancer Symptoms
for
Advanced Breast Cancer, Advanced Prostate Cancer,
Location: Durham NC
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06555588
Recruiting
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Location: Durham NC, Charlotte NC, Fairfax VA, Atlanta GA,
Sponsor: Nuvalent Inc.
Sex: All
Age: 18+
Code: NCT06765109
Phase 3, Recruiting
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
Get alerts for new trials in your area by subscribing now
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
for
Prostate Cancer
Location: Durham NC, Roanoke VA, Athens GA, Washington D.C. DC,
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18 - 70+
Code: NCT05803941
Recruiting
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
for
Prostate Cancer
Location: Durham NC, Basking Ridge NJ, Middletown NJ, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: Male
Age: 18+
Code: NCT06457919
Phase 1, Phase 2, Recruiting
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
for
Metastatic Uveal Melanoma
Location: Durham NC, Knoxville TN, Washington D.C. DC, Atlanta GA,
Sponsor: Replimune Inc.
Sex: All
Age: 0+
Code: NCT06581406
Phase 2, Phase 3, Recruiting
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease